Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform …
Over the last 12 months, insiders at Teladoc Health, Inc. have bought $140,814 and sold $5.62M worth of Teladoc Health, Inc. stock.
On average, over the past 5 years, insiders at Teladoc Health, Inc. have bought $140,814 and sold $167.88M worth of stock each year.
Highest buying activity among insiders over the last 12 months: MCKINLEY THOMAS (director) — $112,502. Smith Mark Douglas (director) — $84,936.
The last purchase of 4,000 shares for transaction amount of $30,756 was made by MCKINLEY THOMAS (director) on 2024‑09‑12.
2024-10-02 | Sale | President, U.S. Group Health | 897 0.0005% | $8.68 | $7,783 | +5.61% | ||
2024-09-12 | director | 4,000 0.0024% | $7.69 | $30,756 | +20.01% | |||
2024-09-04 | Sale | CHIEF MEDICAL OFFICER | 468 0.0003% | $7.26 | $3,398 | +21.51% | ||
2024-09-04 | Sale | EVP, CORPORATE DEVELOPMENT | 20,773 0.0118% | $7.26 | $150,812 | +21.51% | ||
2024-09-03 | Sale | CHIEF FINANCIAL OFFICER | 8,750 0.005% | $7.16 | $62,685 | +22.22% | ||
2024-09-03 | Sale | CHIEF OPERATING OFFICER | 4,218 0.0024% | $7.16 | $30,218 | +22.22% | ||
2024-09-03 | Sale | Chief Technology Officer | 1,033 0.0006% | $7.16 | $7,400 | +22.22% | ||
2024-09-03 | Sale | CHIEF MARKETING OFFICER | 2,083 0.0012% | $7.16 | $14,923 | +22.22% | ||
2024-09-03 | Sale | CHIEF LEGAL OFFICER, SECRETARY | 2,817 0.0016% | $7.16 | $20,181 | +22.22% | ||
2024-09-03 | Sale | CHIEF PEOPLE OFFICER | 1,795 0.001% | $7.16 | $12,859 | +22.22% | ||
2024-09-03 | Sale | EVP, CORPORATE DEVELOPMENT | 1,617 0.0009% | $7.16 | $11,584 | +22.22% | ||
2024-09-03 | Sale | CHIEF MEDICAL OFFICER | 1,114 0.0006% | $7.16 | $7,981 | +22.22% | ||
2024-09-03 | Sale | CHIEF STRATEGY OFFICER | 1,777 0.001% | $7.16 | $12,730 | +22.22% | ||
2024-09-03 | Sale | INTERIM CAO | 555 0.0003% | $7.16 | $3,976 | +22.22% | ||
2024-08-15 | director | 4,000 0.0024% | $7.08 | $28,312 | 0.00% | |||
2024-08-12 | Sale | Chief Technology Officer | 206 0.0001% | $7.13 | $1,470 | +28.97% | ||
2024-08-07 | Sale | CHIEF MARKETING OFFICER | 15,000 0.0093% | $7.60 | $114,000 | +22.97% | ||
2024-08-07 | director | 4,000 0.0023% | $7.19 | $28,756 | +22.97% | |||
2024-08-06 | director | 7,000 0.0041% | $7.57 | $52,990 | +16.82% | |||
2024-08-05 | Sale | CHIEF MEDICAL OFFICER | 1,537 0.0009% | $7.33 | $11,266 | +15.00% |
MCKINLEY THOMAS | director | 39077 0.0227% | $10.67 | 3 | 3 | |
Smith Mark Douglas | director | 8355 0.0049% | $10.67 | 1 | 0 | |
King Michael H. | Chief Sales Officer | 61459 0.0357% | $10.67 | 1 | 5 | +1.52% |
Outland James K | director | 49089 0.0285% | $10.67 | 1 | 2 | +58.22% |
Mead Dana G Jr. | director | 10090 0.0059% | $10.67 | 1 | 0 | +58.22% |
The Vanguard Group | $261.88M | 10.23 | 17.34M | -0.98% | -$2.6M | 0.01 | |
ARK Investment Management LLC | $242.12M | 9.46 | 16.03M | -24.45% | -$78.37M | 0.84 | |
BlackRock | $214.67M | 8.38 | 14.22M | +8.18% | +$16.23M | 0.01 | |
Nikko Asset Management Americas Inc | $108.44M | 4.24 | 7.18M | -3.79% | -$4.28M | 0.81 | |
Sumitomo Mitsui Trust Holdings | $108.44M | 4.24 | 7.18M | -3.92% | -$4.42M | 0.07 |